Resumen de acción AMRUTANJAN
Amrutanjan Health Care Limited fabrica, suministra y vende bálsamos ayurvédicos para el dolor y productos de higiene femenina.
| Puntuación del snowflake | |
|---|---|
| Valoración | 0/6 |
| Crecimiento futuro | 0/6 |
| Rendimiento pasado | 2/6 |
| Salud financiera | 5/6 |
| Dividendos | 4/6 |
Competidores de Amrutanjan Health Care Limited
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | ₹707.20 |
| Máximo en las últimas 52 semanas | ₹862.60 |
| Mínimo de 52 semanas | ₹570.00 |
| Beta | 0.74 |
| 1Cambio en 1 mes | -8.17% |
| Variación en 3 meses | -7.25% |
| Cambio de 1 año | 17.36% |
| 3Variación en 3 años | -25.85% |
| Variación en 5 años | 67.15% |
| Variación desde la OPV | 1,430.40% |
Noticias y actualizaciones recientes
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17Recent updates
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29Rentabilidad de los accionistas
| AMRUTANJAN | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | -7.2% | -0.6% | 0.8% |
| 1Y | 17.4% | 51.3% | 36.2% |
Rentabilidad vs. Industria: Los resultados de AMRUTANJAN fueron inferiores a los de la industria Indian Pharmaceuticals, que obtuvo un rendimiento del 51.3% el año pasado.
Rentabilidad vs. Mercado: AMRUTANJAN obtuvo unos resultados inferiores a los del mercado Indian, que fueron del 36.2% el año pasado.
Volatilidad de los precios
| AMRUTANJAN volatility | |
|---|---|
| AMRUTANJAN Average Weekly Movement | 4.8% |
| Pharmaceuticals Industry Average Movement | 6.3% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.3% |
| 10% least volatile stocks in IN Market | 4.0% |
Precio estable de las acciones: AMRUTANJAN no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de AMRUTANJAN (5%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1893 | 634 | Sambhu Sivalenka | www.amrutanjan.com |
Amrutanjan Health Care Limited fabrica, suministra y vende bálsamos ayurvédicos para el dolor y productos de higiene femenina. La empresa opera a través de los segmentos de Productos OTC, Bebidas y Otros. Ofrece productos para el tratamiento del dolor que comprenden bálsamos y roll-ons para el dolor; y roll-ons para el dolor de espalda, parches adhesivos, geles para el dolor corporal y sprays musculares para las articulaciones.
Resumen de fundamentos de Amrutanjan Health Care Limited
| Estadísticas fundamentales de AMRUTANJAN | |
|---|---|
| Capitalización bursátil | ₹20.44b |
| Beneficios(TTM) | ₹425.73m |
| Ingresos (TTM) | ₹4.27b |
48.0x
Ratio precio-beneficio (PE)4.8x
Ratio precio-ventas (PS)¿Está AMRUTANJAN sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de AMRUTANJAN | |
|---|---|
| Ingresos | ₹4.27b |
| Coste de los ingresos | ₹2.15b |
| Beneficio bruto | ₹2.12b |
| Otros gastos | ₹1.69b |
| Beneficios | ₹425.73m |
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
Nov 12, 2024
| Beneficios por acción (BPA) | 14.73 |
| Margen bruto | 49.61% |
| Margen de beneficio neto | 9.97% |
| Ratio deuda/patrimonio | 0.6% |
¿Cómo se ha desempeñado AMRUTANJAN a largo plazo?
Ver rendimiento histórico y comparativa